NEUMORA THERAPEUTICS, INC. (NMRA) Operating income 2022–2025
NEUMORA THERAPEUTICS, INC. (NMRA) annual operating income history from SEC filings — each fiscal year as reported.
-$241.2MFY2025 · since FY2022: -$135.9M → -$241.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$241.2M | +8.5% |
| FY2024 | -$263.5M | -4.5% |
| FY2023 | -$252.1M | -85.5% |
| FY2022 | -$135.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice